In the Prostate Cancer Early Detection Study Based on a Baseline PSA Value in Young Men trial, screening of ≥45-year-old men revealed that while overall prostate cancer detection rates were low, approximately 70% of screen-detected cancers at this age were clinically significant [11]. The gene discussed is KLK3; the disease is cancer.